Polar Capital Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Polar Capital Holdings’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,095,810	Closed	-$35K	–	460
2022 Q2	$35K	Hold	1,095,810	–	–	0.21%	102
2022 Q1	$38K	Buy	1,095,810 +175,000	+19%	+$5.23M	0.17%	108
2021 Q4	$27K	Sell	920,810 -240,090	-21%	-$7.44M	0.1%	145
2021 Q3	$29.6K	Buy	1,160,900 +410,900	+55%	+$12.1M	0.12%	141
2021 Q2	$26.3K	Hold	750,000	–	–	0.11%	144
2021 Q1	$30.6M	Buy	750,000 +250,000	+50%	+$11.5M	0.19%	127
2020 Q4	$21.7M	Buy	+500,000	New	+$24.7M	0.13%	150

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Polar Capital Holdings's GBT Position: Q3 2022 in Review

Polar Capital Holdings sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 1,095,810 shares — an estimated $35K sold.

Polar Capital Holdings first reported a position in GBT in Q4 2020 and held it in 7 quarters. The position peaked at $30.6M in Q1 2021. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

Polar Capital Holdings reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
Polar Capital Holdings sold 1,095,810 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $35K.
Polar Capital Holdings first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 7 quarters.
Polar Capital Holdings's Global Blood Therapeutics, Inc. position peaked at $30.6M in Q1 2021.
247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.